Inflammation and retinal degenerative diseases

被引:23
|
作者
Kaur, Geetika [1 ,2 ]
Singh, Nikhlesh K. [1 ,2 ]
机构
[1] Wayne State Univ, Integrat Biosci Ctr, Detroit, MI 48202 USA
[2] Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48202 USA
基金
美国国家卫生研究院;
关键词
age-related macular degeneration; diabetic retinopathy; glaucoma; retina; retinal degeneration; retinitis pigmentosa; C-REACTIVE PROTEIN; ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR-H; TUMOR-NECROSIS-FACTOR; MACULAR DEGENERATION; OXIDATIVE STRESS; CELL-DEATH; AGE; PATHOGENESIS; PREVALENCE;
D O I
10.4103/1673-5374.350192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vision is an ability that depends on the precise structure and functioning of the retina. Any kind of stress or injury can disrupt the retinal architecture and leads to vision impairment, vision loss, and blindness. Immune system and immune response function maintain homeostasis in the microenvironment. Several genetic, metabolic, and environmental factors may alter retinal homeostasis, and these events may initiate various inflammatory cascades. The prolonged inflammatory state may contribute to the initiation and development of retinal disorders such as glaucoma, age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, which pose a threat to vision. In the current review, we attempted to provide sufficient evidence on the role of inflammation in these retinal disorders. Moreover, this review paves the way to focus on therapeutic targets of the disease, which are found to be promising.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 50 条
  • [31] Stem Cell Transplantation Therapy for Retinal Degenerative Diseases
    Han, Fabin
    Xu, Guotong
    STEM CELL-BASED THERAPY FOR NEURODEGENERATIVE DISEASES, 2020, 1266 : 127 - 139
  • [32] Pharmacotherapy for metabolic and cellular stress in degenerative retinal diseases
    Kubota, Ryo
    Gregory, Jeff
    Henry, Susan
    Mata, Nathan L.
    DRUG DISCOVERY TODAY, 2020, 25 (02) : 292 - 304
  • [33] Promises of stem cell therapy for retinal degenerative diseases
    Wong, Ian Yat-Hin
    Poon, Ming-Wai
    Pang, Rosita Tsz-Wai
    Lian, Qizhou
    Wong, David
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (10) : 1439 - 1448
  • [34] Retinal Degenerative Diseases Mechanisms and Experimental Therapy Preface
    Ash, John D.
    Anderson, Robert E.
    LaVail, Matthew M.
    Rickman, Catherine Bowes
    Hollyfield, Joe G.
    Grimm, Christian
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 : IX - X
  • [35] Oxidative Stress as a Main Contributor of Retinal Degenerative Diseases
    Pinilla, Isabel
    Maneu, Victoria
    ANTIOXIDANTS, 2022, 11 (06)
  • [36] Selective neuronal cell death in retinal degenerative diseases
    Sakamoto, Kenji
    Mori, Asami
    Ushikubo, Hiroko
    Ishi, Kunio
    Nakahara, Tsutomu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S58 - S58
  • [37] Rod Photoreceptor Temporal Properties in Retinal Degenerative Diseases
    Wen, Y. E.
    Locke, K. G.
    Hood, D. C.
    Birch, D. G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [38] Targeting adenosine receptors for the treatment of retinal degenerative diseases
    Ambrosio, Antonio F.
    PURINERGIC SIGNALLING, 2018, 14 : S31 - S31
  • [39] Gene therapy in inherited retinal degenerative diseases, a review
    Takahashi, Vitor K. L.
    Takiuti, Julia T.
    Jauregui, Ruben
    Tsang, Stephen H.
    OPHTHALMIC GENETICS, 2018, 39 (05) : 560 - 568
  • [40] On the potential therapeutic role of taurine in retinal degenerative diseases
    Garcia-Ayuso, Diego
    Martinez-Vacas, Ana
    Di Pierdomenico, Johnny
    Vidal-Sanz, Manuel
    Soriano, Francisco J. Valiente
    Picaud, Serge
    Villegas-Perez, Maria Paz
    ACTA OPHTHALMOLOGICA, 2024, 102